Ocrelizumab versus Placebo in Primary Progressive Multiple SclerosisNEJM 376:209-220,280, Montalban, X.,et al, 2017
Reactivation of JC Virus and Development of PML in Patients With Multiple SclerosisNeurol 68:985-990, Khalili,K.,et al, 2007